To explore the function of SDS22 in mammalian cells, we engineered the human HCT116 colorectal carcinoma-cell line, using a CRISPR/Cas9 approach, for the inducible proteolytic degradation of endogenous SDS2214. This evidence concerns the gene PPP1R7 and colorectal carcinoma.